Evaluation of amantadine as a releasing agent or uptake blocker for H3-dopamine in rat brain slices (Q44064017)

reason for preferred rank

29 November 2017

title

Evaluation of amantadine as a releasing agent or uptake blocker for H3-dopamine in rat brain slices (English)

1 reference

https://api.crossref.org/works/10.1016/0014-2999(72)90144-6

17 February 2023

Evaluation of amantadine as a releasing agent or uptake blocker for H 3 -dopamine in rat brain slices (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4651205

17 February 2023

0 references

1 reference

https://api.crossref.org/works/10.1016/0014-2999(72)90144-6

17 February 2023

author name string

R. E. Heikkila

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4651205

17 February 2023

G. Cohen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4651205

17 February 2023

language of work or name

English

0 references

publication date

1 November 1972

1 reference

full work available at URL

29 November 2017

https://api.elsevier.com/content/article/PII:0014299972901446?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0014-2999(72)90144-6

https://api.elsevier.com/content/article/PII:0014299972901446?httpAccept=text/plain

17 February 2023

1 reference

https://api.crossref.org/works/10.1016/0014-2999(72)90144-6

European Journal of Pharmacology

17 February 2023

published in

1 reference

29 November 2017

volume

20

1 reference

29 November 2017

issue

2

1 reference

29 November 2017

page(s)

156-160

1 reference

Effects of amantadine hydrochloride on catecholamine metabolism in the brain of the rat.

29 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0014-2999(72)90144-6

Modification of transmitter release by ions which prolong the presynaptic action potential

17 February 2023

2

1 reference

https://api.crossref.org/works/10.1016/0014-2999(72)90144-6

Antiparkinsonian drugs: inhibition of dopamine uptake in the corpus striatum as a possible mechanism of action

17 February 2023

3

1 reference

https://api.crossref.org/works/10.1016/0014-2999(72)90144-6

Dopamine and noradrenaline releasing action of amantadine in the central and peripheral nervous system: a possible mode of action in Parkinson's disease

17 February 2023

4

1 reference

https://api.crossref.org/works/10.1016/0014-2999(72)90144-6

Amantadine-Dopamine Interaction: Possible Mode of Action in Parkinsonism

17 February 2023

5

1 reference

https://api.crossref.org/works/10.1016/0014-2999(72)90144-6

Effects of temperature and drugs on mammalian motor nerve terminals

17 February 2023

7

1 reference

https://api.crossref.org/works/10.1016/0014-2999(72)90144-6

The effect of guanidine on neuromuscular transmission

17 February 2023

9

1 reference

https://api.crossref.org/works/10.1016/0014-2999(72)90144-6

Increased synthesis and release of dopamine in the striatum of the rat after amantadine treatment

17 February 2023

11

1 reference

https://api.crossref.org/works/10.1016/0014-2999(72)90144-6

Further Studies on the Mode of Action of Amantadine

17 February 2023

15

1 reference

https://api.crossref.org/works/10.1016/0014-2999(72)90144-6

On the mode of action of amantadine

17 February 2023

16

1 reference

https://api.crossref.org/works/10.1016/0014-2999(72)90144-6

Dopamine: Release from the Brain in vivo by Amantadine

17 February 2023

17

1 reference

https://api.crossref.org/works/10.1016/0014-2999(72)90144-6

17 February 2023

Identifiers

1 reference

29 November 2017

1 reference